383 related articles for article (PubMed ID: 29598981)
1. Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.
Kinsella N; Stattin P; Cahill D; Brown C; Bill-Axelson A; Bratt O; Carlsson S; Van Hemelrijck M
Eur Urol; 2018 Sep; 74(3):261-280. PubMed ID: 29598981
[TBL] [Abstract][Full Text] [Related]
2. Patient and disease factors affecting the choice and adherence to active surveillance.
Dall'Era MA
Curr Opin Urol; 2015 May; 25(3):272-6. PubMed ID: 25692724
[TBL] [Abstract][Full Text] [Related]
3. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
4. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
5. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial aspects of active surveillance.
Kazer MW; Psutka SP; Latini DM; Bailey DE
Curr Opin Urol; 2013 May; 23(3):273-7. PubMed ID: 23422588
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
10. Patient reported factors influencing the decision-making process of men with localised prostate cancer when considering Active Surveillance-A systematic review and thematic synthesis.
Cunningham M; Murphy M; Sweeney P; Richards HL
Psychooncology; 2022 Mar; 31(3):388-404. PubMed ID: 34605104
[TBL] [Abstract][Full Text] [Related]
11. Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review.
Kith G; Lisker S; Sarkar U; Barr-Walker J; Breyer BN; Palmer NR
Eur Urol Oncol; 2021 Apr; 4(2):192-201. PubMed ID: 31288992
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer support groups, health literacy and consumerism: are community-based volunteers re-defining older men's health?
Oliffe JL; Bottorff JL; McKenzie MM; Hislop TG; Gerbrandt JS; Oglov V
Health (London); 2011 Nov; 15(6):555-70. PubMed ID: 21177714
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
[TBL] [Abstract][Full Text] [Related]
14. Men's perspectives on selecting their prostate cancer treatment.
Xu J; Dailey RK; Eggly S; Neale AV; Schwartz KL
J Natl Med Assoc; 2011 Jun; 103(6):468-78. PubMed ID: 21830629
[TBL] [Abstract][Full Text] [Related]
15. Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature.
Bierbaum M; Rapport F; Arnolda G; Nic Giolla Easpaig B; Lamprell K; Hutchinson K; Delaney GP; Liauw W; Kefford R; Olver I; Braithwaite J
Implement Sci; 2020 May; 15(1):39. PubMed ID: 32460797
[TBL] [Abstract][Full Text] [Related]
16. Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men.
Rogers CR; Rovito MJ; Hussein M; Obidike OJ; Pratt R; Alexander M; Berge JM; Dall'Era M; Nix JW; Warlick C
Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S103-S111. PubMed ID: 30670195
[TBL] [Abstract][Full Text] [Related]
17. A qualitative meta-synthesis examining the role of women in African American men's prostate cancer screening and treatment decision making.
Bergner EM; Cornish EK; Horne K; Griffith DM
Psychooncology; 2018 Mar; 27(3):781-790. PubMed ID: 29055290
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Willemse PM; Davis NF; Grivas N; Zattoni F; Lardas M; Briers E; Cumberbatch MG; De Santis M; Dell'Oglio P; Donaldson JF; Fossati N; Gandaglia G; Gillessen S; Grummet JP; Henry AM; Liew M; MacLennan S; Mason MD; Moris L; Plass K; O'Hanlon S; Omar MI; Oprea-Lager DE; Pang KH; Paterson CC; Ploussard G; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TBL
Eur Urol; 2022 Apr; 81(4):337-346. PubMed ID: 34980492
[TBL] [Abstract][Full Text] [Related]
19. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
20. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
